Four pathology laboratories in the US have adopted PathAI’s enterprise workflow solution, AISight Image Management System ...

RFK Jr. should accept the ruling and instruct the agency to immediately halt all efforts to regulate laboratory-developed and ...

Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...

The Digital Pathology Market is expected to witness a growth rate of ~10.5% by 2029. The key factors driving the market are ...

A federal judge in Texas has blocked the FDA’s plans to bring laboratory-developed tests under the same regulations it uses ...

The global US Digital Pathology Market is projected to reach US$2.01 billion by 2029 from US$1.05 billion in 2024, at a CAGR of 13.1%. The US ...

With the adoption of AISight®, Annapath Laboratories, PPMG, PGL, and SigmaCore join a growing network of independent pathology laboratories leveraging digital pathology to enhance operational ...

A federal judge ruled Monday that the FDA doesn’t have the legal authority to regulate lab-developed tests, dealing a blow to ...

AISight® is a cloud-native, intelligent enterprise workflow solution designed to help laboratories streamline pathology workflows, enhance case assignment and image management, and integrate AI ...